IKT 株価推移チャート
IKT 株価予測
Inhibikase Therapeutics Inc
$2.35
0.85%
$0.02
終値： Jul 27, 16:00:00 GMT-4
$2.39
1.7%
$0.04
アフターマーケット：Jul 27, 20:00:00 GMT-4
戻る
Inhibikase Therapeutics Inc (IKT) 株価予測
主要データ
前終値
$2.33
始値
$2.36
当日レンジ
$2.31 - $2.39
52週レンジ
$1.33 - $2.39
取引高
494.2K
平均取引高
1.0M
配当利回り
--
1株当たり利益(TTM)
-1.15
時価総額
$315.5M
IKTとは何ですか？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
